| P50 | author | Yevgeniya Gartshteyn | Q92006105 |
| | Marina Cerrone | Q38327725 |
| P2093 | author name string | Joan M Bathon | |
| | Jon T Giles | |
| | Afshin Zartoshti | |
| | Anca D Askanase | |
| | Laura Geraldino-Pardilla | |
| | Paloma Piña | |
| P2860 | cites work | The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis | Q27860872 |
| | Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus | Q29614922 |
| | Electrocardiographic findings in systemic lupus erythematosus: data from an international inception cohort | Q30823425 |
| | Association of electrocardiographic abnormalities with coronary artery calcium and carotid artery intima-media thickness in individuals without clinical coronary heart disease (from the Multi-Ethnic Study of Atherosclerosis [MESA]) | Q33854378 |
| | QT interval: how to measure it and what is "normal" | Q83211169 |
| | AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part IV: the ST segment, T and U waves, and the QT interval: a scientific statement from the American Heart Association Electrocardiography and Arrhyth | Q83467835 |
| | Anti-Ro/SSA-associated corrected QT interval prolongation in adults: the role of antibody level and specificity | Q84523987 |
| | Evaluation of serum interleukin-6 level as a surrogate marker of synovial inflammation and as a factor of structural progression in early rheumatoid arthritis: results from a French national multicenter cohort | Q85937709 |
| | Elevated IL-1β levels in anti-Ro/SSA connective tissue diseases patients with prolonged corrected QTc interval | Q86018187 |
| | Systemic inflammation and arrhythmic risk: lessons from rheumatoid arthritis | Q89349466 |
| | Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus | Q33974679 |
| | Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus | Q34098573 |
| | QT dispersion in patients with systemic lupus erythematosus: the impact of disease activity | Q34173567 |
| | Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis | Q34182804 |
| | Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis | Q34315745 |
| | Prolonged QTc interval predicts all-cause mortality in patients with rheumatoid arthritis: an association driven by high inflammatory burden | Q34375590 |
| | The QT interval is associated with incident cardiovascular events: the MESA study | Q34626199 |
| | Prevalences of ECG findings in large population based samples of men and women | Q35377288 |
| | Systematic review and meta-analysis of methotrexate use and risk of cardiovascular disease | Q35377706 |
| | Cardiac manifestations of neonatal lupus: a review of autoantibody-associated congenital heart block and its impact in an adult population | Q35745465 |
| | Clinical significance of minor nonspecific ST-segment and T-wave abnormalities in asymptomatic subjects: a systematic review | Q36793514 |
| | Hydroxychloroquine Use Is Associated With Decreased Incident Cardiovascular Events in Rheumatoid Arthritis Patients | Q36877859 |
| | Coronary arterial calcification in rheumatoid arthritis: comparison with the Multi-Ethnic Study of Atherosclerosis | Q37206907 |
| | Marked QTc Prolongation and Torsades de pointes in Patients with Chronic Inflammatory Arthritis. | Q37268104 |
| | Major and minor electrocardiographic abnormalities and their association with underlying cardiovascular disease and risk factors in Hispanics/Latinos (from the Hispanic Community Health Study/Study of Latinos). | Q37396447 |
| | Cardiovascular disease a hazard despite improved prognosis in patients with systemic lupus erythematosus: results from a Swedish population based study 1964-95. | Q38479125 |
| | Heart rate-corrected QT interval prolongation predicts risk of coronary heart disease in black and white middle-aged men and women: the ARIC study | Q39676709 |
| | Arrhythmogenicity of Anti-Ro/SSA Antibodies in Patients With Torsades de Pointes. | Q39875887 |
| | Mortality studies in systemic lupus erythematosus. Results from a single center. I. Causes of death. | Q40415334 |
| | Overall and cause-specific mortality in systemic lupus erythematosus: an updated meta-analysis | Q40817900 |
| | Pathogenesis of the Novel Autoimmune-Associated Long-QT Syndrome | Q40917363 |
| | The bimodal mortality pattern of systemic lupus erythematosus | Q43703475 |
| | Overall and cause-specific mortality in patients with systemic lupus erythematosus: a meta-analysis of observational studies. | Q43861291 |
| | Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. | Q44441787 |
| | The association between the length of the QT interval and mortality in the Cardiovascular Health Study | Q44666633 |
| | All-cause mortality and vascular events among patients with rheumatoid arthritis, osteoarthritis, or no arthritis in the UK General Practice Research Database. | Q44724213 |
| | Prolonged corrected QT interval in anti-Ro/SSA-positive adults with systemic lupus erythematosus | Q45804571 |
| | Prevalence of conduction abnormalities in a systolic heart failure population by race, ethnicity, and gender. | Q45900420 |
| | Impact of minor electrocardiographic ST-segment and/or T-wave abnormalities on cardiovascular mortality during long-term follow-up | Q47953154 |
| | Association of nonspecific minor ST-T abnormalities with cardiovascular mortality: the Chicago Western Electric Study. | Q50638299 |
| | Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in Northern Sweden. | Q50969877 |
| | Association between corrected QT interval and inflammatory cytokines in rheumatoid arthritis. | Q53642786 |
| | Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis. | Q53725487 |
| | QT interval prolongation predicts cardiovascular mortality in an apparently healthy population | Q68004588 |
| | QTc prolongation measured by standard 12-lead electrocardiography is an independent risk factor for sudden death due to cardiac arrest | Q70168089 |
| | Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study | Q73106702 |
| | QT dispersion increases in patients with systemic lupus erythematosus | Q80080638 |
| | Comparison of frequency of complex ventricular arrhythmias in patients with positive versus negative anti-Ro/SSA and connective tissue disease | Q81160587 |
| | Cardiac involvement in systemic lupus erythematosus | Q81338407 |
| P433 | issue | 1 | |
| P921 | main subject | systemic lupus erythematosus | Q1485 |
| | rheumatoid arthritis | Q187255 |
| | lupus erythematosus | Q188297 |
| P304 | page(s) | e000168 | |
| P577 | publication date | 2016-12-16 | |
| P1433 | published in | Lupus science & medicine | Q27725658 |
| P1476 | title | ECG non-specific ST-T and QTc abnormalities in patients with systemic lupus erythematosus compared with rheumatoid arthritis | |
| P478 | volume | 3 | |